ADAG

Adagene Inc.

NasdaqAdd to watchlist

Healthcare · Biotechnology

$3.31

−$0.06−1.78%

Delayed · 2026-09-18T20:00:00.000Z · marketstack

Aug 24, 2026$3.31

−$0.59−15.13%over 1M

Session

Day range42% of range

$3.17$3.51

Fundamentals

Visualize fundamentals and more

Market cap: -
P/E ratio: -

Revenue grew +7332.76% in FY2025, +7323.89% faster than its sector. The median across Healthcare companies this platform tracks is +8.87%.

Recent activity

Sep 16 Luo Peter bought 20,290 shares Insider trading Form 4 Chief Executive Officer, about $64k
Sep 10 Material event Company filing 6-K
Sep 9 Material event Company filing 6-K

12 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 18, 2026 · the last close

Adagene Inc. investor relations

What ADAG has filed with the SEC. This is not Adagene Inc.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like Adagene Inc.

Also filed under Biotechnology, ranked by how closely they sit beside ADAG.

MRNAModerna, Inc.compare with ADAG
ROIVRoivant Sciences Ltd.compare with ADAG
VRTXVertex Pharmaceuticals Inc. / MAcompare with ADAG
XENE

Ask about Adagene Inc.

The assistant answers from what ADAG has actually filed: 8 annual reports filed with the SEC and 4 Form 4 filings from the last year. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from ADAG's filings and figures. One a day without an account; a free account has its own, and no card.

What an account lets you do with Adagene Inc.

Be told the moment a ADAG insider trades
Put Adagene Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Adagene Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Adagene Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.